1.995
1.27%
+0.025
Vivani Medical Inc stock is currently priced at $1.995, with a 24-hour trading volume of 155.98K.
It has seen a +1.27% increased in the last 24 hours and a +8.42% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.95 pivot point. If it approaches the $2.02 resistance level, significant changes may occur.
Previous Close:
$1.97
Open:
$1.99
24h Volume:
155.98K
Market Cap:
$109.68M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-5.1154
EPS:
-0.39
Net Cash Flow:
$-24.59M
1W Performance:
+10.22%
1M Performance:
+8.42%
6M Performance:
+103.86%
1Y Performance:
+58.33%
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
818 833 5000
Address
5858 Horton Street, Suite 280, EmeryVille
Vivani Medical Inc Stock (VANI) Latest News
Vivani Medical Inc [VANI] Investment Guide: What You Need to Know – Knox Daily - Knox Daily
Knox Daily
Vivani Medical Shares Operational Updates at Conferences - TipRanks.com - TipRanks
TipRanks
Vivani Medical: Q1 Earnings Snapshot | News | bakersfield.com - The Bakersfield Californian
The Bakersfield Californian
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results - Business Wire
Business Wire
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Up 18.5% in April - Defense World
Defense World
Vivani Medical: Q1 Earnings Snapshot - Milford Mirror
Milford Mirror
Vivani Medical Inc Stock (VANI) Financials Data
Vivani Medical Inc (VANI) Net Income 2024
VANI net income (TTM) was -$25.65 million for the quarter ending December 31, 2023, a -84.71% decrease year-over-year.
Vivani Medical Inc (VANI) Cash Flow 2024
VANI recorded a free cash flow (TTM) of -$24.59 million for the quarter ending December 31, 2023, a -28.55% decrease year-over-year.
Vivani Medical Inc (VANI) Earnings per Share 2024
VANI earnings per share (TTM) was -$0.49 for the quarter ending December 31, 2023, a -44.33% decline year-over-year.
Vivani Medical Inc Stock (VANI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Williams Gregg | Director |
Feb 09 '24 |
Buy |
1.01 |
1,071 |
1,082 |
726,530 |
Williams Gregg | Director |
Feb 08 '24 |
Buy |
1.01 |
1,119 |
1,130 |
725,459 |
Williams Gregg | Director |
Feb 06 '24 |
Buy |
1.01 |
56 |
57 |
724,340 |
Williams Gregg | Director |
Feb 05 '24 |
Buy |
1.01 |
1,939 |
1,958 |
724,284 |
Williams Gregg | Director |
Jan 31 '24 |
Buy |
1.01 |
100 |
101 |
722,345 |
Williams Gregg | Director |
Jan 23 '24 |
Buy |
1.01 |
834 |
842 |
722,245 |
Williams Gregg | Director |
Jan 22 '24 |
Buy |
1.01 |
7,620 |
7,696 |
721,411 |
Williams Gregg | Director |
Jan 19 '24 |
Buy |
1.01 |
77 |
78 |
713,791 |
Williams Gregg | Director |
Jan 18 '24 |
Buy |
1.01 |
999 |
1,009 |
713,714 |
Williams Gregg | Director |
Jan 16 '24 |
Buy |
1.01 |
13,067 |
13,198 |
712,715 |
About Vivani Medical Inc
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Cap:
|
Volume (24h):